Vaccines Archive — Page 13 of 14
-
July 9, 2015
Study could lead to vaccine for mosquito-borne dengue virus
Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus. -
April 8, 2015
VU joins national effort to speed Ebola therapy testing
Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus. -
January 29, 2015
Core facilities key driver of VUMC research gains
During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care. -
November 13, 2014
Speaker explores promise of ‘bioelectronic medicine’
Can an implanted electrical device like a cardiac pacemaker effectively treat inflammatory diseases like rheumatoid arthritis, including cases that have not responded to drug therapy? -
September 18, 2014
Initiative seeks to develop therapies to combat Ebola
Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. -
April 7, 2014
Vanderbilt Vaccine Center joins global task force to address urgent viral threat
-
March 6, 2014
Multi-center effort targets lethal Ebola, Marburg viruses
Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections.